Page last updated: 2024-08-16

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and 4-(2-chlorophenyl)butan-2-amine

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with 4-(2-chlorophenyl)butan-2-amine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cote, SR; Kuzhikandathil, EV1

Other Studies

1 other study(ies) available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and 4-(2-chlorophenyl)butan-2-amine

ArticleYear
In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
    Neuropharmacology, 2014, Volume: 79

    Topics: Animals; Benzopyrans; Butylamines; Cell Line, Tumor; Cerebral Cortex; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Exploratory Behavior; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Motor Activity; Oxazines; Phosphorylation; Receptors, Dopamine D3

2014